Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

BACKGROUND: Despite improvement in the overall survival of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation, the effects of EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment on bone metastasis remain unclear. This study investigated radiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyagi, Michihito, Katagiri, Hirohisa, Murata, Hideki, Wasa, Junji, Takahashi, Toshiaki, Murakami, Haruyasu, Harada, Hideyuki, Mori, Keita, Takahashi, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801654/
https://www.ncbi.nlm.nih.gov/pubmed/36581856
http://dx.doi.org/10.1186/s12890-022-02226-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801654/
https://www.ncbi.nlm.nih.gov/pubmed/36581856
http://dx.doi.org/10.1186/s12890-022-02226-1

Ejemplares similares